{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:51:39Z","timestamp":1783569099558,"version":"3.55.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01555-8","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:01:57Z","timestamp":1728399717000},"page":"279-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?"],"prefix":"10.1007","volume":"83","author":[{"given":"Sina Kalantari","family":"Soltanieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Khastar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwanjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beneen","family":"Husseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Rajabivahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Dehghani-Ghorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"11","key":"1555_CR1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R., & Sanyal, A. J. (2013). The global NAFLD epidemic. Nature Reviews Gastroenterology & Hepatology, 10(11), 686\u2013690.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"1","key":"1555_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","volume":"35","author":"MS Mundi","year":"2020","unstructured":"Mundi, M. S., et al. (2020). Evolution of NAFLD and its management. Nutrition in Clinical Practice, 35(1), 72\u201384.","journal-title":"Nutrition in Clinical Practice"},{"key":"1555_CR3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese, M., et al. (2016). Innate immunity and inflammation in NAFLD\/NASH. Digestive Diseases and Sciences, 61, 1294\u20131303.","journal-title":"Digestive Diseases and Sciences"},{"issue":"10","key":"1555_CR4","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","volume":"71","author":"J-F Dufour","year":"2022","unstructured":"Dufour, J.-F., et al. (2022). Current therapies and new developments in NASH. Gut, 71(10), 2123\u20132134.","journal-title":"Gut"},{"key":"1555_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone, F., Razori, M. V., & Roma, M. G. (2019). Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences, 76, 99\u2013128.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"1555_CR6","doi-asserted-by":"crossref","unstructured":"Dai, W., et al. (2017). Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine, 96 (39), e8179.","DOI":"10.1097\/MD.0000000000008179"},{"issue":"5","key":"1555_CR7","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","volume":"15","author":"W Peverill","year":"2014","unstructured":"Peverill, W., Powell, L. W., & Skoien, R. (2014). Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. International Journal of Molecular Sciences, 15(5), 8591\u20138638.","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"1555_CR8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8), 1038\u20131048.","journal-title":"Metabolism"},{"issue":"3","key":"1555_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbrc.2015.03.095","volume":"460","author":"JH Yu","year":"2015","unstructured":"Yu, J. H., et al. (2015). Monoacylglycerol O-acyltransferase 1 is regulated by peroxisome proliferator-activated receptor \u03b3 in human hepatocytes and increases lipid accumulation. Biochemical and Biophysical Research Communications, 460(3), 715\u2013720.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"1555_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012). Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology and Medicine, 52(1), 59\u201369.","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"1555_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai, D., et al. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nature Medicine, 11(2), 183\u2013190.","journal-title":"Nature Medicine"},{"issue":"6","key":"1555_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","volume":"1791","author":"WS Blaner","year":"2009","unstructured":"Blaner, W. S., et al. (2009). Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1791(6), 467\u2013473.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"issue":"4","key":"1555_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3350\/cmh.2020.0166","volume":"26","author":"S Han","year":"2020","unstructured":"Han, S., et al. (2020). Long non-coding RNAs in liver diseases: focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease. Clinical and Molecular hepatology, 26(4), 705.","journal-title":"Clinical and Molecular hepatology"},{"issue":"20","key":"1555_CR14","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.3390\/ijms232012370","volume":"23","author":"I Rusu","year":"2022","unstructured":"Rusu, I., et al. (2022). The implications of noncoding rnas in the evolution and progression of nonalcoholic fatty liver disease (Nafld)-related hcc. International Journal of Molecular Sciences, 23(20), 12370.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1555_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03296-3","volume":"24","author":"N Karamali","year":"2024","unstructured":"Karamali, N., et al. (2024). Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer. Cancer Cell International, 24(1), 104.","journal-title":"Cancer Cell International"},{"issue":"2","key":"1555_CR16","doi-asserted-by":"crossref","first-page":"100584","DOI":"10.1016\/j.aohep.2021.100584","volume":"27","author":"S-S Jin","year":"2022","unstructured":"Jin, S.-S., et al. (2022). Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p\/c-Jun\/SREBP-1c pathway. Annals of Hepatology, 27(2), 100584.","journal-title":"Annals of Hepatology"},{"issue":"1","key":"1555_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0379-6","volume":"11","author":"M Zhang","year":"2018","unstructured":"Zhang, M., et al. (2018). The lncRNA NEAT1 activates Wnt\/\u03b2-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. Journal of Hematology & Oncology, 11(1), 1\u201313.","journal-title":"Journal of Hematology & Oncology"},{"issue":"4","key":"1555_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/JME-18-0098","volume":"61","author":"Y-H Bai","year":"2018","unstructured":"Bai, Y.-H., et al. (2018). LncRNA NEAT1 promotes inflammatory response and induces corneal neovascularization. Journal of Molecular Endocrinology, 61(4), 231\u2013239.","journal-title":"Journal of Molecular Endocrinology"},{"key":"1555_CR19","doi-asserted-by":"crossref","first-page":"116829","DOI":"10.1016\/j.lfs.2019.116829","volume":"235","author":"X Chen","year":"2019","unstructured":"Chen, X., et al. (2019). LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease. Life Sciences, 235, 116829.","journal-title":"Life Sciences"},{"issue":"1","key":"1555_CR20","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/21691401.2019.1604536","volume":"47","author":"X Fu","year":"2019","unstructured":"Fu, X., et al. (2019). Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 1782\u20131787.","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"issue":"2","key":"1555_CR21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcb.26317","volume":"119","author":"X Wang","year":"2018","unstructured":"Wang, X. (2018). Down\u2010regulation of lncRNA\u2010NEAT1 alleviated the non\u2010alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway. Journal of Cellular Biochemistry, 119(2), 1567\u20131574.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"1555_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2019.06.104","volume":"516","author":"Y Sun","year":"2019","unstructured":"Sun, Y., et al. (2019). LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK\/SREBP-1 signaling. Biochemical and Biophysical Research communications, 516(2), 584\u2013590.","journal-title":"Biochemical and Biophysical Research communications"},{"key":"1555_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","volume":"131","author":"H Yao","year":"2018","unstructured":"Yao, H., et al. (2018). Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway. Pharmacological Research, 131, 51\u201360.","journal-title":"Pharmacological Research"},{"issue":"12","key":"1555_CR24","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1172\/JCI63562","volume":"128","author":"H Huang","year":"2018","unstructured":"Huang, H., et al. (2018). Rho-kinase\/AMPK axis regulates hepatic lipogenesis during overnutrition. The Journal of Clinical Investigation, 128(12), 5335\u20135350.","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"1555_CR25","first-page":"2593","volume":"14","author":"W Zhou","year":"2022","unstructured":"Zhou, W., & Qiu, K. (2022). The correlation between lncRNA NEAT1 and serum hepcidin in the peripheral blood of non-alcoholic fatty liver disease patients. American Journal of Translational Research, 14(4), 2593.","journal-title":"American Journal of Translational Research"},{"key":"1555_CR26","doi-asserted-by":"crossref","first-page":"734643","DOI":"10.3389\/fmed.2021.734643","volume":"8","author":"J Lu","year":"2022","unstructured":"Lu, J., et al. (2022). Long non-coding RNA MALAT1: a key player in liver diseases. Frontiers in Medicine, 8, 734643.","journal-title":"Frontiers in Medicine"},{"key":"1555_CR27","doi-asserted-by":"crossref","first-page":"858558","DOI":"10.3389\/fbioe.2022.858558","volume":"10","author":"J Xiang","year":"2022","unstructured":"Xiang, J., et al. (2022). LncRNA MALAT1 promotes PPAR\u03b1\/CD36-mediated hepatic lipogenesis in nonalcoholic fatty liver disease by modulating miR-206\/ARNT axis. Frontiers in Bioengineering and Biotechnology, 10, 858558.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"8","key":"1555_CR28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/cells12081205","volume":"12","author":"M Zaiou","year":"2023","unstructured":"Zaiou, M. (2023). Peroxisome proliferator-activated receptor-\u03b3 as a target and regulator of epigenetic mechanisms in nonalcoholic fatty liver disease. Cells, 12(8), 1205.","journal-title":"Cells"},{"issue":"7","key":"1555_CR29","doi-asserted-by":"crossref","first-page":"BSR20181722","DOI":"10.1042\/BSR20181722","volume":"39","author":"J Liu","year":"2019","unstructured":"Liu, J., et al. (2019). LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a\/PPAR\u03b3 axis in non-alcoholic fatty liver disease. Bioscience Reports, 39(7), BSR20181722.","journal-title":"Bioscience Reports"},{"issue":"5","key":"1555_CR30","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.29654","volume":"67","author":"C Liu","year":"2018","unstructured":"Liu, C., et al. (2018). Long noncoding RNA H19 interacts with polypyrimidine tract\u2010binding protein 1 to reprogram hepatic lipid homeostasis. Hepatology, 67(5), 1768\u20131783.","journal-title":"Hepatology"},{"issue":"2","key":"1555_CR31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/jcmm.14818","volume":"24","author":"H Wang","year":"2020","unstructured":"Wang, H., et al. (2020). Long non\u2010coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes. Journal of Cellular and Molecular Medicine, 24(2), 1399\u20131412.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"9","key":"1555_CR32","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.3390\/nu13092952","volume":"13","author":"S Di Mauro","year":"2021","unstructured":"Di Mauro, S., et al. (2021). Coffee restores expression of lncRNAs involved in steatosis and fibrosis in a mouse model of NAFLD. Nutrients, 13(9), 2952.","journal-title":"Nutrients"},{"issue":"4","key":"1555_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41419-022-04717-9","volume":"13","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y., et al. (2022). SIX5-activated LINC01468 promotes lung adenocarcinoma progression by recruiting SERBP1 to regulate SERPINE1 mRNA stability and recruiting USP5 to facilitate PAI1 protein deubiquitylation. Cell Death & Disease, 13(4), 312.","journal-title":"Cell Death & Disease"},{"issue":"15","key":"1555_CR34","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/cancers13153740","volume":"13","author":"C Zhang","year":"2021","unstructured":"Zhang, C., & Yang, M. (2021). The emerging factors and treatment options for NAFLD-related hepatocellular carcinoma. Cancers, 13(15), 3740.","journal-title":"Cancers"},{"issue":"1","key":"1555_CR35","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang, H., et al. (2022). LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2. Cell Death Discovery, 8(1), 449.","journal-title":"Cell Death Discovery"},{"issue":"25","key":"1555_CR36","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong, H., et al. (2017). LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene, 36(25), 3528\u20133540.","journal-title":"Oncogene"},{"issue":"10","key":"1555_CR37","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1002\/jcp.28450","volume":"234","author":"X Shen","year":"2019","unstructured":"Shen, X., et al. (2019). Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. Journal of Cellular Physiology, 234(10), 18169\u201318179.","journal-title":"Journal of Cellular Physiology"},{"key":"1555_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1086-5","volume":"20","author":"H Wu","year":"2020","unstructured":"Wu, H., et al. (2020). LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1\/M2 polarization of Kupffer cells. Cancer Cell International, 20, 1\u201311.","journal-title":"Cancer Cell International"},{"issue":"7","key":"1555_CR39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1194\/jlr.RA120000664","volume":"61","author":"M Ma","year":"2020","unstructured":"Ma, M., et al. (2020). The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice [S]. Journal of Lipid Research, 61(7), 1052\u20131064.","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"1555_CR40","volume":"23","author":"B Ye","year":"2022","unstructured":"Ye, B., et al. (2022). The role of ZNF143 overexpression in rat liver cell proliferation. BMC Genomics, 23(1), 483.","journal-title":"BMC Genomics"},{"issue":"1","key":"1555_CR41","doi-asserted-by":"crossref","first-page":"2239592","DOI":"10.1080\/15592294.2023.2239592","volume":"18","author":"Y Dong","year":"2023","unstructured":"Dong, Y., et al. (2023). ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway. Epigenetics, 18(1), 2239592.","journal-title":"Epigenetics"},{"key":"1555_CR42","doi-asserted-by":"crossref","first-page":"109129","DOI":"10.1016\/j.biopha.2019.109129","volume":"118","author":"S Ghafouri-Fard","year":"2019","unstructured":"Ghafouri-Fard, S., & Taheri, M. (2019). Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA. Biomedicine & Pharmacotherapy, 118, 109129.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"1555_CR43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jb\/mvz097","volume":"167","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., et al. (2020). LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. The Journal of Biochemistry, 167(3), 295\u2013301.","journal-title":"The Journal of Biochemistry"},{"key":"1555_CR44","doi-asserted-by":"crossref","first-page":"109379","DOI":"10.1016\/j.cellsig.2019.109379","volume":"63","author":"D You","year":"2019","unstructured":"You, D., et al. (2019). Long non-coding RNA MEG3 inhibits chondrogenic differentiation of synovium-derived mesenchymal stem cells by epigenetically inhibiting TRIB2 via methyltransferase EZH2. Cellular Signalling, 63, 109379.","journal-title":"Cellular Signalling"},{"issue":"1","key":"1555_CR45","volume":"8","author":"D Zou","year":"2022","unstructured":"Zou, D., et al. (2022). LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease. Cell Death Discovery, 8(1), 103.","journal-title":"Cell Death Discovery"},{"issue":"15","key":"1555_CR46","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1111\/jcmm.16764","volume":"25","author":"P Yuan","year":"2021","unstructured":"Yuan, P., et al. (2021). LncRNA MAYA promotes iron overload and hepatocyte senescence through inhibition of YAP in non\u2010alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine, 25(15), 7354\u20137366.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"1555_CR47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2018.03.127","volume":"499","author":"M Zhang","year":"2018","unstructured":"Zhang, M., et al. (2018). Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt\/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Biochemical and Biophysical Research Communications, 499(1), 66\u201370.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1555_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-02189-8","volume":"18","author":"Y Chi","year":"2020","unstructured":"Chi, Y., et al. (2020). Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2\/AKT pathway. Journal of Translational Medicine, 18, 1\u201311.","journal-title":"Journal of Translational Medicine"},{"key":"1555_CR49","doi-asserted-by":"crossref","unstructured":"Xu, F., et al. (2020). LncRNA Gm12664 up-regulates CAV1 expression to promote hepatocellular lipid accumulation by sponging miR-295-5p. Nutrition & Metabolism, 17:13.","DOI":"10.1101\/2020.02.15.951095"},{"issue":"1","key":"1555_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-022-00723-y","volume":"17","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., et al. (2020). LncRNA Gm12664\u2013001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression. Nutrition & Metabolism, 17(1), 1\u20138.","journal-title":"Nutrition & Metabolism"},{"issue":"10","key":"1555_CR51","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/carcin\/bgv099","volume":"36","author":"R Tao","year":"2015","unstructured":"Tao, R., et al. (2015). Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis, 36(10), 1136\u20131143.","journal-title":"Carcinogenesis"},{"key":"1555_CR52","doi-asserted-by":"crossref","first-page":"889858","DOI":"10.3389\/fendo.2022.889858","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu, S., et al. (2022). LncRNA GAS5 knockdown mitigates hepatic lipid accumulation via regulating MiR-26a-5p\/PDE4B to activate cAMP\/CREB pathway. Frontiers in Endocrinology, 13, 889858.","journal-title":"Frontiers in Endocrinology"},{"issue":"5","key":"1555_CR53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/genes11050545","volume":"11","author":"M-H Han","year":"2020","unstructured":"Han, M.-H., et al. (2020). Expression of the long noncoding RNA GAS5 correlates with liver fibrosis in patients with nonalcoholic fatty liver disease. Genes, 11(5), 545.","journal-title":"Genes"},{"issue":"4","key":"1555_CR54","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1080\/21655979.2022.2026858","volume":"13","author":"J Cui","year":"2022","unstructured":"Cui, J., Wang, Y., & Xue, H. (2022). Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p\/NOTCH2 axis. Bioengineered, 13(4), 8370\u20138381.","journal-title":"Bioengineered"},{"key":"1555_CR55","doi-asserted-by":"crossref","unstructured":"Chen, T., et al. (2023) GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis. Cell Death & Differentiation, 1\u201320.","DOI":"10.1038\/s41418-023-01183-4"},{"issue":"12","key":"1555_CR56","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1002\/jcp.29795","volume":"235","author":"F Huang","year":"2020","unstructured":"Huang, F., et al. (2020). Long noncoding RNA CCAT1 inhibits miR\u2010613 to promote nonalcoholic fatty liver disease via increasing LXR\u03b1 transcription. Journal of Cellular Physiology, 235(12), 9819\u20139833.","journal-title":"Journal of Cellular Physiology"},{"key":"1555_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-021-00620-w","volume":"19","author":"X Ge","year":"2022","unstructured":"Ge, X., et al. (2022). The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease. Nutrition & Metabolism, 19, 1\u201311.","journal-title":"Nutrition & Metabolism"},{"issue":"7","key":"1555_CR58","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cbf.3495","volume":"38","author":"T Li","year":"2020","unstructured":"Li, T., et al. (2020). Knockdown of long non\u2010coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non\u2010alcoholic fatty liver disease. Cell Biochemistry and Function, 38(7), 839\u2013846.","journal-title":"Cell Biochemistry and Function"},{"issue":"3","key":"1555_CR59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00335-022-09945-0","volume":"33","author":"J Yin","year":"2022","unstructured":"Yin, J., et al. (2022). RMRP inhibition prevents NAFLD progression in rats via regulating miR-206\/PTPN1 axis. Mammalian Genome, 33(3), 480\u2013489.","journal-title":"Mammalian Genome"},{"issue":"4","key":"1555_CR60","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2016.12.016","volume":"66","author":"H Wu","year":"2017","unstructured":"Wu, H., et al. (2017). MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. Journal of Hepatology, 66(4), 816\u2013824.","journal-title":"Journal of Hepatology"},{"issue":"2","key":"1555_CR61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/ATVBAHA.118.311817","volume":"39","author":"F Ye","year":"2019","unstructured":"Ye, F., et al. (2019). Angiotensinogen and megalin interactions contribute to atherosclerosis\u2014brief report. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(2), 150\u2013155.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"1555_CR62","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1080\/21655979.2021.1960463","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen, X., et al. (2021). Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. Bioengineered, 12(1), 6738\u20136747.","journal-title":"Bioengineered"},{"issue":"27","key":"1555_CR63","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","volume":"24","author":"Y-L Fang","year":"2018","unstructured":"Fang, Y.-L., et al. (2018). Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model. World Journal of Gastroenterology, 24(27), 2974.","journal-title":"World Journal of Gastroenterology"},{"key":"1555_CR64","unstructured":"(2021). LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-$$\\kappa {} $$ \u03ba B\/JNK pathway by endoplasmic reticulum stress.Journal of Translational Medicine, 19(1), 1\u201315."},{"key":"1555_CR65","doi-asserted-by":"crossref","unstructured":"Liu, D., et al. (2022). Nonalcoholic fatty liver hepatocyte-derived lncRNA MALAT1 aggravates pancreatic cell inflammation via the inhibition of autophagy by upregulating YAP. Computational Intelligence and Neuroscience, 2022(1), 2930960.","DOI":"10.1155\/2022\/2930960"},{"key":"1555_CR66","doi-asserted-by":"crossref","first-page":"198405","DOI":"10.1016\/j.virusres.2021.198405","volume":"298","author":"J-Z Li","year":"2021","unstructured":"Li, J.-Z., et al. (2021). The identify role and molecular mechanism of the MALAT1\/hsa-mir-20b-5p\/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405.","journal-title":"Virus Research"},{"issue":"8","key":"1555_CR67","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/cells10081883","volume":"10","author":"B Atanasovska","year":"2021","unstructured":"Atanasovska, B., et al. (2021). Long non-coding RNAs involved in progression of non-alcoholic fatty liver disease to steatohepatitis. Cells, 10(8), 1883.","journal-title":"Cells"},{"issue":"2","key":"1555_CR68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/biomedicines11020574","volume":"11","author":"MG Erdem","year":"2023","unstructured":"Erdem, M. G., Unlu, O., & Demirci, M. (2023). Could long non-coding RNA MEG3 and PTENP1 interact with miR-21 in the pathogenesis of non-alcoholic fatty liver disease? Biomedicines, 11(2), 574.","journal-title":"Biomedicines"},{"issue":"1","key":"1555_CR69","doi-asserted-by":"crossref","first-page":"102067","DOI":"10.1016\/j.clinre.2022.102067","volume":"47","author":"L Liu","year":"2023","unstructured":"Liu, L., Sun, S., & Li, X. (2023). LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation. Clinics and Research in Hepatology and Gastroenterology, 47(1), 102067.","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"4","key":"1555_CR70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/ncrna8040056","volume":"8","author":"M Ilieva","year":"2022","unstructured":"Ilieva, M., et al. (2022). Systematic analysis of long non-coding RNA genes in nonalcoholic fatty liver disease. Non-Coding RNA, 8(4), 56.","journal-title":"Non-Coding RNA"},{"issue":"6","key":"1555_CR71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1017\/S0007114522001829","volume":"129","author":"W Yang","year":"2023","unstructured":"Yang, W., et al. (2023). Long non-coding RNA-EN_181 potentially contributes to the protective effects of N-acetylcysteine against non-alcoholic fatty liver disease in mice. British Journal of Nutrition, 129(6), 921\u2013935.","journal-title":"British Journal of Nutrition"},{"issue":"1","key":"1555_CR72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/thno.50281","volume":"11","author":"Y Lin","year":"2021","unstructured":"Lin, Y., et al. (2021). Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice. Theranostics, 11(1), 426.","journal-title":"Theranostics"},{"issue":"24","key":"1555_CR73","doi-asserted-by":"crossref","first-page":"16054","DOI":"10.3390\/ijms232416054","volume":"23","author":"W Yang","year":"2022","unstructured":"Yang, W., et al. (2022). Long noncoding RNAs in the pathogenesis of insulin resistance. International Journal of Molecular Sciences, 23(24), 16054.","journal-title":"International Journal of Molecular Sciences"},{"key":"1555_CR74","doi-asserted-by":"crossref","unstructured":"Xia, Y., Zhang, Y., & Wang, H. (2021). Upregulated lncRNA HCG18 in patients with non-alcoholic fatty liver disease and its regulatory effect on insulin resistance. Diabetes, Metabolic Syndrome and Obesity, 14, 4747-4756.","DOI":"10.2147\/DMSO.S333431"},{"key":"1555_CR75","doi-asserted-by":"crossref","unstructured":"Zhang, H., et al. (2021). Effect of LncPVT1\/miR-20a-5p on lipid metabolism and insulin resistance in NAFLD. Diabetes, Metabolic Syndrome and Obesity, 14, 4599-4608.","DOI":"10.2147\/DMSO.S338097"},{"issue":"26","key":"1555_CR76","doi-asserted-by":"crossref","first-page":"22522","DOI":"10.1021\/acsomega.2c01801","volume":"7","author":"W Xue","year":"2022","unstructured":"Xue, W., et al. (2022). Identify functional lncRNAs in nonalcoholic fatty liver disease by constructing a ceRNA network. ACS Omega, 7(26), 22522\u201322530.","journal-title":"ACS Omega"},{"key":"1555_CR77","doi-asserted-by":"crossref","first-page":"653902","DOI":"10.3389\/fonc.2021.653902","volume":"11","author":"D Ma","year":"2021","unstructured":"Ma, D., et al. (2021). Fucoidan inhibits the progression of hepatocellular carcinoma via causing lncRNA LINC00261 overexpression. Frontiers in Oncology, 11, 653902.","journal-title":"Frontiers in Oncology"},{"issue":"35","key":"1555_CR78","doi-asserted-by":"crossref","first-page":"59638","DOI":"10.18632\/oncotarget.19559","volume":"8","author":"C Zheng","year":"2017","unstructured":"Zheng, C., et al. (2017). lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget, 8(35), 59638.","journal-title":"Oncotarget"},{"issue":"22","key":"1555_CR79","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.3390\/ijms20225613","volume":"20","author":"G Pennisi","year":"2019","unstructured":"Pennisi, G., et al. (2019). The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: screening issue and future perspectives. International Journal of Molecular Sciences, 20(22), 5613.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"1555_CR80","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/jcp.29230","volume":"235","author":"X Li","year":"2020","unstructured":"Li, X., et al. (2020). LncRNA NEAT1 promotes autophagy via regulating miR\u2010204\/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma. Journal of Cellular Physiology, 235(4), 3402\u20133413.","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"1555_CR81","doi-asserted-by":"crossref","first-page":"3801748","DOI":"10.1155\/2020\/3801748","volume":"2020","author":"H Wu","year":"2020","unstructured":"Wu, H., et al. (2020). Four autophagy\u2010related lncRNAs predict the prognosis of HCC through coexpression and ceRNA mechanism. BioMed Research International, 2020(1), 3801748.","journal-title":"BioMed Research International"},{"key":"1555_CR82","unstructured":"Wang, X., et al. (2020). LncRNA DANCR promotes ATG7 expression to accelerate hepatocellular carcinoma cell proliferation and autophagy by sponging miR-222-3p. European Review for Medical & Pharmacological Sciences, 24, (17), 8778\u20138787."},{"issue":"5","key":"1555_CR83","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/hep.26195","volume":"57","author":"JF Huang","year":"2013","unstructured":"Huang, J. F., et al. (2013). Hepatitis B virus X protein (HBx)\u2010related long noncoding RNA (lncRNA) down\u2010regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology, 57(5), 1882\u20131892.","journal-title":"Hepatology"},{"key":"1555_CR84","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s12032-011-0004-z","volume":"29","author":"M-C Lai","year":"2012","unstructured":"Lai, M.-C., et al. (2012). Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Medical Oncology, 29, 1810\u20131816.","journal-title":"Medical Oncology"},{"key":"1555_CR85","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1245\/s10434-011-1581-y","volume":"18","author":"Z Yang","year":"2011","unstructured":"Yang, Z., et al. (2011). Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Annals of Surgical Oncology, 18, 1243\u20131250.","journal-title":"Annals of Surgical Oncology"},{"issue":"6","key":"1555_CR86","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1159\/000495056","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., et al. (2018). HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition via the miR-520c-3p\/GPC3 axis in hepatocellular carcinoma. Cellular Physiology and Biochemistry, 50(6), 2124\u20132138.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"1555_CR87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000495231","volume":"51","author":"Y Wu","year":"2018","unstructured":"Wu, Y., et al. (2018). Long noncoding RNA HOST2 promotes epithelial-mesenchymal transition, proliferation, invasion and migration of hepatocellular carcinoma cells by activating the JAK2-STAT3 signaling pathway. Cellular Physiology and Biochemistry, 51(1), 301\u2013314.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"1555_CR88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biopha.2016.06.056","volume":"83","author":"W Peng","year":"2016","unstructured":"Peng, W., & Fan, H. (2016). Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK\/MAPK pathway. Biomedicine & Pharmacotherapy, 83, 450\u2013455.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1555_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-020-00255-2","volume":"27","author":"J Wang","year":"2021","unstructured":"Wang, J., et al. (2021). LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma. Molecular Medicine, 27, 1\u201310.","journal-title":"Molecular Medicine"},{"issue":"4","key":"1555_CR90","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3892\/ijo.2016.3385","volume":"48","author":"J-Y Zhang","year":"2016","unstructured":"Zhang, J.-Y., et al. (2016). Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA\/Rac2 signaling. International Journal of Oncology, 48(4), 1590\u20131598.","journal-title":"International Journal of Oncology"},{"key":"1555_CR91","doi-asserted-by":"crossref","first-page":"105846","DOI":"10.1016\/j.phrs.2021.105846","volume":"172","author":"X-F Peng","year":"2021","unstructured":"Peng, X.-F., et al. (2021). Targeting epigenetics and lncRNAs in liver disease: from mechanisms to therapeutics. Pharmacological Research, 172, 105846.","journal-title":"Pharmacological Research"},{"issue":"4","key":"1555_CR92","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","volume":"5","author":"A Gonzalez-Rodriguez","year":"2014","unstructured":"Gonzalez-Rodriguez, A., et al. (2014). Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death & Disease, 5(4), e1179\u2013e1179.","journal-title":"Cell Death & Disease"},{"issue":"7242","key":"1555_CR93","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh, R., et al. (2009). Autophagy regulates lipid metabolism. Nature, 458(7242), 1131\u20131135.","journal-title":"Nature"},{"issue":"3","key":"1555_CR94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","volume":"14","author":"T Ueno","year":"2017","unstructured":"Ueno, T., & Komatsu, M. (2017). Autophagy in the liver: functions in health and disease. Nature Reviews Gastroenterology & Hepatology, 14(3), 170\u2013184.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"4","key":"1555_CR95","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3350\/cmh.2020.0173","volume":"26","author":"YS Kim","year":"2020","unstructured":"Kim, Y. S., & Kim, S. G. (2020). Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases. Clinical and Molecular Hepatology, 26(4), 715.","journal-title":"Clinical and Molecular Hepatology"},{"key":"1555_CR96","doi-asserted-by":"crossref","first-page":"931928","DOI":"10.3389\/fgene.2022.931928","volume":"13","author":"Z Cao","year":"2022","unstructured":"Cao, Z., et al. (2022). Identifying autophagy-related lncRNAs and potential ceRNA networks in NAFLD. Frontiers in Genetics, 13, 931928.","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"1555_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-018-1541-0","volume":"17","author":"Z Ye","year":"2019","unstructured":"Ye, Z., et al. (2019). Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma. World Journal of Surgical Oncology, 17(1), 1\u201310.","journal-title":"World Journal of Surgical Oncology"},{"issue":"1","key":"1555_CR98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M., & Lash, A. E. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research, 30(1), 207\u2013210.","journal-title":"Nucleic Acids Research"},{"key":"1555_CR99","doi-asserted-by":"crossref","unstructured":"Dudley, J. T. & Butte, A. J. (2009). Identification of discriminating biomarkers for human disease using integrative network biology. Biocomputing 2009, World Scientific. p. 27\u201338.","DOI":"10.1142\/9789812836939_0004"},{"issue":"13","key":"1555_CR100","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.3390\/ijms22136770","volume":"22","author":"M Matboli","year":"2021","unstructured":"Matboli, M., et al. (2021). mRNA-miRNA-lncRNA regulatory network in nonalcoholic fatty liver disease. International Journal of Molecular Sciences, 22(13), 6770.","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"1555_CR101","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/biomedicines9091248","volume":"9","author":"R Albadawy","year":"2021","unstructured":"Albadawy, R., et al. (2021). Clinical significance of hspd1\/mmp14\/itgb1\/mir-6881-5p\/lnc-sparcl1-1: 2 rna panel in nafld\/nash diagnosis: Egyptian pilot study. Biomedicines, 9(9), 1248.","journal-title":"Biomedicines"},{"issue":"11","key":"1555_CR102","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.bbadis.2014.08.015","volume":"1842","author":"Y He","year":"2014","unstructured":"He, Y., et al. (2014). Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease, 1842(11), 2204\u20132215.","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease"},{"issue":"24","key":"1555_CR103","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1080\/15384101.2015.1120917","volume":"14","author":"F Yu","year":"2015","unstructured":"Yu, F., et al. (2015). MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis. Cell Cycle, 14(24), 3885\u20133896.","journal-title":"Cell Cycle"},{"issue":"3","key":"1555_CR104","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbadis.2016.12.009","volume":"1863","author":"E-B Bian","year":"2017","unstructured":"Bian, E.-B., et al. (2017). Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(3), 674\u2013686.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"1555_CR105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-017-1586-5","volume":"95","author":"F Yu","year":"2017","unstructured":"Yu, F., et al. (2017). NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6. Journal of Molecular Medicine, 95, 1191\u20131202.","journal-title":"Journal of Molecular Medicine"},{"issue":"1","key":"1555_CR106","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang, K., et al. (2017). The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGF\u03b2 and Notch pathways. Nature Communications, 8(1), 144.","journal-title":"Nature Communications"},{"issue":"4","key":"1555_CR107","first-page":"2649","volume":"19","author":"H Wu","year":"2019","unstructured":"Wu, H., et al. (2019). Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non\u2011alcoholic fatty liver disease. Molecular Medicine Reports, 19(4), 2649\u20132659.","journal-title":"Molecular Medicine Reports"},{"key":"1555_CR108","doi-asserted-by":"crossref","unstructured":"Rehati, A., et al. (2023). Identification of heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease. Genes & Immunity, 24(3):124\u2013129.","DOI":"10.1038\/s41435-023-00205-y"},{"issue":"10","key":"1555_CR109","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/life10100230","volume":"10","author":"JG Park","year":"2020","unstructured":"Park, J. G., et al. (2020). Plasma long noncoding RNA LeXis is a potential diagnostic marker for non-alcoholic steatohepatitis. Life, 10(10), 230.","journal-title":"Life"},{"issue":"12","key":"1555_CR110","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/iub.2137","volume":"71","author":"B Wang","year":"2019","unstructured":"Wang, B., et al. (2019). Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization. IUBMB Life, 71(12), 1952\u20131961.","journal-title":"IUBMB Life"},{"issue":"1","key":"1555_CR111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/liv.14270","volume":"40","author":"TA Labeur","year":"2020","unstructured":"Labeur, T. A., et al. (2020). Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver International, 40(1), 215\u2013228.","journal-title":"Liver International"},{"issue":"1","key":"1555_CR112","first-page":"8126208","volume":"2018","author":"X Hu","year":"2018","unstructured":"Hu, X., et al. (2018). A systematic review of long noncoding RNAs in hepatocellular carcinoma: molecular mechanism and clinical implications. BioMed Research International, 2018(1), 8126208.","journal-title":"BioMed Research International"},{"key":"1555_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13072-017-0130-8","volume":"10","author":"JR Edwards","year":"2017","unstructured":"Edwards, J. R., et al. (2017). DNA methylation and DNA methyltransferases. Epigenetics & chromatin, 10, 1\u201310.","journal-title":"Epigenetics & chromatin"},{"key":"1555_CR114","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.toxlet.2018.07.013","volume":"295","author":"J-J Yang","year":"2018","unstructured":"Yang, J.-J., et al. (2018). DNMT1 controls LncRNA H19\/ERK signal pathway in hepatic stellate cell activation and fibrosis. Toxicology Letters, 295, 325\u2013334.","journal-title":"Toxicology Letters"},{"issue":"4","key":"1555_CR115","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/jcmm.14987","volume":"24","author":"JJ Yang","year":"2020","unstructured":"Yang, J. J., et al. (2020). Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway. Journal of Cellular and Molecular Medicine, 24(4), 2677\u20132687.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1555_CR116","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ebiom.2018.08.055","volume":"36","author":"D Cheng","year":"2018","unstructured":"Cheng, D., et al. (2018). LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine, 36, 159\u2013170.","journal-title":"EBioMedicine"},{"issue":"2","key":"1555_CR117","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2014.09.033","volume":"62","author":"A Page","year":"2015","unstructured":"Page, A., et al. (2015). Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. Journal of Hepatology, 62(2), 388\u2013397.","journal-title":"Journal of Hepatology"},{"issue":"2","key":"1555_CR118","first-page":"718","volume":"43","author":"B Jiang","year":"2020","unstructured":"Jiang, B., et al. (2020). lncRNA PVT1 promotes hepatitis B virus\u2011positive liver cancer progression by disturbing histone methylation on the c\u2011Myc promoter. Oncology Reports, 43(2), 718\u2013726.","journal-title":"Oncology Reports"},{"issue":"4","key":"1555_CR119","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ajpath.2011.01.002","volume":"178","author":"B Hu","year":"2011","unstructured":"Hu, B., et al. (2011). Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. The American Journal of Pathology, 178(4), 1500\u20131508.","journal-title":"The American Journal of Pathology"},{"key":"1555_CR120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2013.04.008","volume":"309","author":"E-B Bian","year":"2013","unstructured":"Bian, E.-B., et al. (2013). The role of methyl-CpG binding protein 2 in liver fibrosis. Toxicology, 309, 9\u201314.","journal-title":"Toxicology"},{"issue":"2","key":"1555_CR121","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","volume":"138","author":"J Mann","year":"2010","unstructured":"Mann, J., et al. (2010). MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology, 138(2), 705\u2013714.e4.","journal-title":"Gastroenterology"},{"key":"1555_CR122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2016.06.016","volume":"359","author":"J-J Yang","year":"2016","unstructured":"Yang, J.-J., et al. (2016). MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R. Toxicology, 359, 39\u201346.","journal-title":"Toxicology"},{"issue":"5","key":"1555_CR123","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1053\/j.gastro.2019.07.029","volume":"157","author":"E Moran-Salvador","year":"2019","unstructured":"Moran-Salvador, E., et al. (2019). Fibrogenic activity of MECP2 is regulated by phosphorylation in hepatic stellate cells. Gastroenterology, 157(5), 1398\u20131412.e9.","journal-title":"Gastroenterology"},{"issue":"1","key":"1555_CR124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrg1981","volume":"8","author":"YB Schwartz","year":"2007","unstructured":"Schwartz, Y. B., & Pirrotta, V. (2007). Polycomb silencing mechanisms and the management of genomic programmes. Nature Reviews Genetics, 8(1), 9\u201322.","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"1555_CR125","volume":"9","author":"J Guo","year":"2018","unstructured":"Guo, J., et al. (2018). Ultraconserved element uc. 372 drives hepatic lipid accumulation by suppressing miR-195\/miR4668 maturation. Nature Communications, 9(1), 612.","journal-title":"Nature Communications"},{"issue":"8","key":"1555_CR126","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.18632\/aging.103020","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., et al. (2020). Ultraconserved element uc. 333 increases insulin sensitivity by binding to miR-223. Aging, 12(8), 6667.","journal-title":"Aging"},{"key":"1555_CR127","doi-asserted-by":"crossref","unstructured":"Hu, M.-J., Long, M., & Dai, R.-J. (2022). Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p\/GRIA3. Molecular and Cellular Biochemistry, 477(1): 191\u2013203.","DOI":"10.1007\/s11010-021-04269-0"},{"key":"1555_CR128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10238-020-00636-1","volume":"20","author":"H Yang","year":"2020","unstructured":"Yang, H., et al. (2020). LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2. Clinical and Experimental Medicine, 20, 587\u2013600.","journal-title":"Clinical and Experimental Medicine"},{"issue":"9","key":"1555_CR129","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/liv.14167","volume":"39","author":"S Di Mauro","year":"2019","unstructured":"Di Mauro, S., et al. (2019). Serum coding and non\u2010coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver International, 39(9), 1742\u20131754.","journal-title":"Liver International"},{"issue":"11","key":"1555_CR130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte, M. (2015). The emerging role of lncRNAs in cancer. Nature Medicine, 21(11), 1253\u20131261.","journal-title":"Nature Medicine"},{"issue":"1","key":"1555_CR131","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","volume":"132","author":"K Panzitt","year":"2007","unstructured":"Panzitt, K., et al. (2007). Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132(1), 330\u2013342.","journal-title":"Gastroenterology"},{"issue":"5","key":"1555_CR132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrurol.2009.40","volume":"6","author":"D Hessels","year":"2009","unstructured":"Hessels, D., & Schalken, J. A. (2009). The use of PCA3 in the diagnosis of prostate cancer. Nature Reviews Urology, 6(5), 255\u2013261.","journal-title":"Nature Reviews Urology"},{"issue":"1","key":"1555_CR133","first-page":"5417598","volume":"2020","author":"J Huang","year":"2020","unstructured":"Huang, J., et al. (2020). A circulating long noncoding RNA panel serves as a diagnostic marker for hepatocellular carcinoma. Disease Markers, 2020(1), 5417598.","journal-title":"Disease Markers"},{"issue":"1","key":"1555_CR134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41392-019-0080-7","volume":"4","author":"Y Li","year":"2019","unstructured":"Li, Y., et al. (2019). The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduction and Targeted Therapy, 4(1), 47.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5992","key":"1555_CR135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","volume":"329","author":"M-C Tsai","year":"2010","unstructured":"Tsai, M.-C., et al. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329(5992), 689\u2013693.","journal-title":"Science"},{"issue":"2","key":"1555_CR136","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/jcb.29364","volume":"121","author":"MI Qadir","year":"2020","unstructured":"Qadir, M. I., et al. (2020). RNA therapeutics: Identification of novel targets leading to drug discovery. Journal of Cellular Biochemistry, 121(2), 898\u2013929.","journal-title":"Journal of Cellular Biochemistry"},{"key":"1555_CR137","doi-asserted-by":"crossref","unstructured":"Mehmandar-Oskuie, A., et al. (2023). Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches. Life Sciences, p. 122322.","DOI":"10.1016\/j.lfs.2023.122322"},{"key":"1555_CR138","doi-asserted-by":"crossref","first-page":"115242","DOI":"10.1016\/j.biopha.2023.115242","volume":"165","author":"A Mehmandar-Oskuie","year":"2023","unstructured":"Mehmandar-Oskuie, A., et al. (2023). Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies. Biomedicine & Pharmacotherapy, 165, 115242.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7539","key":"1555_CR139","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","volume":"518","author":"L Meng","year":"2015","unstructured":"Meng, L., et al. (2015). Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature, 518(7539), 409\u2013412.","journal-title":"Nature"},{"issue":"7","key":"1555_CR140","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., et al. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908\u2013922.","journal-title":"Nature Medicine"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01555-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01555-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01555-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:33:10Z","timestamp":1740724390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01555-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01555-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"17 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}